1. Home
  2. CRVL vs MDGL Comparison

CRVL vs MDGL Comparison

Compare CRVL & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVL
  • MDGL
  • Stock Information
  • Founded
  • CRVL 1987
  • MDGL 2011
  • Country
  • CRVL United States
  • MDGL United States
  • Employees
  • CRVL N/A
  • MDGL N/A
  • Industry
  • CRVL Specialty Insurers
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRVL Finance
  • MDGL Health Care
  • Exchange
  • CRVL Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • CRVL 5.6B
  • MDGL 6.1B
  • IPO Year
  • CRVL 1991
  • MDGL N/A
  • Fundamental
  • Price
  • CRVL $104.34
  • MDGL $295.17
  • Analyst Decision
  • CRVL
  • MDGL Strong Buy
  • Analyst Count
  • CRVL 0
  • MDGL 9
  • Target Price
  • CRVL N/A
  • MDGL $420.63
  • AVG Volume (30 Days)
  • CRVL 146.6K
  • MDGL 306.4K
  • Earning Date
  • CRVL 07-29-2025
  • MDGL 08-06-2025
  • Dividend Yield
  • CRVL N/A
  • MDGL N/A
  • EPS Growth
  • CRVL 24.49
  • MDGL N/A
  • EPS
  • CRVL 1.83
  • MDGL N/A
  • Revenue
  • CRVL $895,589,000.00
  • MDGL $317,383,000.00
  • Revenue This Year
  • CRVL N/A
  • MDGL $286.17
  • Revenue Next Year
  • CRVL N/A
  • MDGL $64.17
  • P/E Ratio
  • CRVL $56.16
  • MDGL N/A
  • Revenue Growth
  • CRVL 12.61
  • MDGL N/A
  • 52 Week Low
  • CRVL $83.37
  • MDGL $200.63
  • 52 Week High
  • CRVL $128.61
  • MDGL $377.46
  • Technical
  • Relative Strength Index (RSI)
  • CRVL 43.62
  • MDGL 57.17
  • Support Level
  • CRVL $101.46
  • MDGL $277.64
  • Resistance Level
  • CRVL $105.51
  • MDGL $314.22
  • Average True Range (ATR)
  • CRVL 2.38
  • MDGL 11.63
  • MACD
  • CRVL 0.07
  • MDGL 2.76
  • Stochastic Oscillator
  • CRVL 34.69
  • MDGL 63.41

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: